Skip to content
Search

Latest Stories

All pharmacy system suppliers in Wales now support EPS

Electronic prescribing service (EPS) in Wales
pharmacist with digital tablet checking prescription(gettyimages)

Since the launch of EPS in November 2023, more than 700,000 prescription items have been dispensed using the service in Wales

Three more pharmacy system suppliers have received approval to roll out their software in community pharmacies to support electronic prescribing service (EPS) in Wales.

The approval means all seven pharmacy system suppliers who have contracts with pharmacies in Wales can now deliver EPS.


Digital Health and Care Wales (DHCW) announced on 17 January 2025 that healthcare technology firms Cegedim Rx, EMIS and PharmacyX have successfully developed and tested systems capable of handling electronic prescriptions.

“Following robust monitoring, any pharmacy using the suppliers' software will be able to use EPS, providing they have completed a number of readiness activities,” DHCW stated.

System suppliers Invatech, Boots, Positive Solutions and Clanwilliam completed testing of their software systems last year.

Apotec is currently undergoing the assurance process, according to DHCW.

This development marks a significant milestone in DHCW’s aim to move from a paper-based prescription process to a digital system.

“EPS makes things easier, safer and more efficient for patients and healthcare staff, as well as helping the environment as it reduces the amount of paper we print,” the organisation noted.

Jenny Pugh-Jones, programme oversight chair for the primary care EPS programme at DHCW, highlighted the collaborative efforts among suppliers, EPS programme team, community pharmacies, GP practices and other partners in achieving this milestone.

“EPS brings a number of benefits to patients in Wales, and I’m delighted it will now reach more areas in the coming months,” she said.

Since the launch of EPS in November 2023, more than 700,000 prescription items have been dispensed via the service, according to DHCW. The service is currently available in 25 GP practices and more than 150 pharmacies across Wales.

Testing of Pharmacy Systems

EMIS’s ProScript Connect pharmacy system was tested at the G. Rowe pharmacies in Nantymoel and Ogmore Vale, Bridgend, in partnership with Nantymoel Surgery.

The software can be used at pharmacies using ProScript Connect as well as those that have a contract with AAH.

Sima Jassal, clinical director of pharmacy at EMIS, commented: “Delivering the Electronic Prescription Service to our ProScript Connect users across Wales is another important step forwards for community pharmacy - making dispensing more efficient and safer for patients.”

PharmacyX, the only Wales-based pharmacy system to achieve EPS accreditation, tested its software at Health Plus Pharmacy in Blaenavon in collaboration with Blaenavon Medical Practice.

Pharmacy X Director Paul Mayberry stated: “As a homegrown solution, PharmacyX is uniquely positioned to meet the needs of Welsh pharmacies, and we look forward to supporting their journey into this exciting digital future.”

Cegedim Rx’s Pharmacy Manager software was tested at two branches of Nelson’s Pharmacy in Tredegar, Blaenau Gwent.

Cegedim Rx managing director Tracey Robertson remarked: “The benefits of the EPS programme are far reaching. It enables pharmacies and GP practices to work more efficiently, while also enabling patients to easily and conveniently access the care they need.”

EPS is a key part of the Digital Medicines transformation programme, managed by DHCW.

All system suppliers are supported by the Community Pharmacy System Innovation Fund, established by Life Sciences Hub Wales (LSHW) and Digital Medicines on behalf of the Welsh Government.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less